Hepatitis B and C: Management and Treatment, 2nd Edition (Hardback) book cover

Hepatitis B and C

Management and Treatment, 2nd Edition

By Thierry Poynard

CRC Press

176 pages | 50 B/W Illus.

Purchasing Options:$ = USD
Hardback: 9781841843698
pub: 2004-08-25
$110.00
x
eBook (VitalSource) : 9780203357187
pub: 2004-08-25
from $28.98


FREE Standard Shipping!

Description

Chronic hepatitis B and C affect 520 million people worldwide, and are a major cause of chronic liver disease and of mortality, despite the efficacy of the vaccine. Hepatitis B and C: Management and Treatment second edition provides a practical explanation of the natural history and management of the disease, and examines the benefits of the most recent drugs, and their effects, whether used in isolation or as part of a combination therapy. This second edition expands the coverage of treatment of various difficult-to-treat patients and will be a welcome guide to the physician in both clinical decision-making and in explaining the benefits and side-effects to the patient.

Table of Contents

HEPATITIS C

Introduction

Natural History of Hepatitis C: Epidemiology

Natural History of Hepatitis C: Hepatic Manifestations

Natural History of Hepatitis C: Extra-hepatic Manifestations and Quality of Life

Management Protocols in Chronic Hepatitis C

Management of Relapsers and Non Responders, Maintenance Therapy

Management of Patients with Cirrhosis

Management of Patients Co-infected by HCV and HIV

Management of HCV Infection Post Liver Transplantation

Management of Patients with Renal Disease

Safety of Interferon, Pegylated Interferon and Ribavirin

Who Need to be Treated?

Cost-effectiveness of Treatment. Management of Acute Hepatitis C

Difficult-to-treat Patients

Practical Guidelines for the Management of Hepatitis C

New Drugs in Development

HEPATITIS B

Introduction

Natural History of Hepatitis B: Epidemiology

Natural History of Hepatitis B: Hepatic Manifestations

Natural History of Hepatitis B: Extra-hepatic Manifestations and Quality of Life

The Goal of Treatment in Chronic Hepatitis B

Efficacy of Interferon and Pegylated Interferon

Efficacy of Lamivudine

Efficacy of Adefovir

Comparison Between Lamivudine, Interferon and Adefovir, and Combinations

Safety of Lamivudine

Safety of Adefovir

New Drugs in Development

First Line Treatment of Chronic Hepatitis B: Adefovir, Lamivudine or Interferon?

Who Need to be Treated and How to Explain the Goals to the Patient?

Management of Relapsers and Non Responders

Management of Patients Co-infected by HBV and HIV

Management of Transplanted Patients Infected by HBV

Cost-effectiveness of Treatment. Section 3: Biochemical Markers, an Alternative to Liver Biopsies

Advantage and Limits of Liver Biopsy

Advantage and Limits of Biochemical Markers

Subject Categories

BISAC Subject Codes/Headings:
MED022090
MEDICAL / Infectious Diseases
MED031000
MEDICAL / Gastroenterology